Reis, Ana Luiza Guimarães
Maximino, Jessica Ruivo
Lage, Luis Alberto de Padua Covas
Gomes, Hélio Rodrigues
Pereira, Juliana
Brofman, Paulo Roberto Slud
Senegaglia, Alexandra Cristina
Rebelatto, Carmen Lúcia Kuniyoshi
Daga, Debora Regina
Paiva, Wellingson Silva
Chadi, Gerson http://orcid.org/0000-0002-9667-0716
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (401922/2014-6)
Ministério da Saúde (836458/2016)
Financiadora de Estudos e Projetos (1701/22)
Article History
Received: 24 November 2023
Accepted: 27 June 2024
First Online: 15 September 2024
Declarations
:
: The study was approved by the Ethics Committee of the Clinics Hospital of the University of Sao Paulo (Approval Number: 1.616.004; Date of Approval: June, 30th 2016). Project Registration Number: 37772414.0.0000.0068. Original Title of Approved Project: Estudo fase 1/2 da segurança e eficácia de duas doses intratecais de células-tronco mesenquimais autólogas (CTM), obtidas de células estromais da medula óssea, em pacientes com Esclerose Lateral Amiotrófica. English Title of Approved Project (Translated): Phase 1/2 clinical trial on security and efficiency of 2 doses of intrathecal infusion of bone marrow derived autologous Mesenchymal Stem Cell (MSC) in Amyotrophic Lateral Sclerosis ALS patients provided informed consent in accordance with the Helsinki declaration.
: Not applicable.
: The authors declare that they have no conflict of interest.